Institutional investors purchased a net $4.2 million shares of VICL during the quarter ended September 2014, and now own 36.97% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BOSTON PRIVATE BANK & TRUST CO. Bought 25.0 Thousand shares of Vical Inc